Live feed
Filing
SC 13D/A
SC 13D/A0000919574-20-005961·CAXTON CORP
Schedule 13D ownership disclosure
Strongbridge Biopharma plc
Security class unavailable · CUSIP: G85347105
Event date: 2020-09-17
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 15.2000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000919574-20-005961
- Form type
- SC 13D/A
- Filer
- CAXTON CORP
- CIK
- CIK 1388551
- Filed
- Sep 23, 2020
- Reporting period
- Sep 17, 2020
- Description
- Schedule 13D beneficial ownership